Avinger, Inc. (AVGR)
NASDAQ: AVGR · IEX Real-Time Price · USD
1.760
-0.040 (-2.22%)
At close: Jul 19, 2024, 4:00 PM
1.690
-0.070 (-3.98%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Avinger Market Cap
Avinger has a market cap or net worth of $3.58 million as of July 22, 2024. Its market cap has decreased by -52.31% in one year.
Market Cap
3.58M
Enterprise Value
11.15M
1-Year Change
-52.31%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since January 30, 2015, Avinger's market cap has decreased from $132.80M to $3.58M, a decrease of -97.31%. That is a compound annual growth rate of -31.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.00M | -18.92% |
| Dec 29, 2023 | 3.70M | -54.32% |
| Dec 30, 2022 | 8.10M | -81.16% |
| Dec 31, 2021 | 43.00M | 14.97% |
| Dec 31, 2020 | 37.40M | 216.95% |
| Dec 31, 2019 | 11.80M | 68.57% |
| Dec 31, 2018 | 7.00M | 22.81% |
| Dec 29, 2017 | 5.70M | -93.25% |
| Dec 30, 2016 | 84.40M | -70.50% |
| Dec 31, 2015 | 286.10M | 115.44% |
| Jan 30, 2015 | 132.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Concept | 3.75M |
| Enveric Biosciences | 3.74M |
| Fresh2 Group | 3.70M |
| Scinai Immunotherapeutics | 3.68M |
| Applied DNA Sciences | 3.63M |
| Lipella Pharmaceuticals | 3.48M |
| Xylo Technologies | 3.41M |
| Aptevo Therapeutics | 3.39M |